Evidence-Based Medicine Guidelines
Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dabigatran Versus Vitamin K Antagonists in Non-valvular Atrial Fibrillation." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation.
Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation. Accessed November 30, 2023.
Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation
Dabigatran Versus Vitamin K Antagonists in Non-valvular Atrial Fibrillation [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation
ID - 458232
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
